PDB Short entry for 4N6O HEADER HYDROLASE/HYDROLASE INHIBITOR 14-OCT-13 4N6O TITLE CRYSTAL STRUCTURE OF REDUCED LEGUMAIN IN COMPLEX WITH CYSTATIN E/M COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEGUMAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 26-303; COMPND 5 SYNONYM: ASPARAGINYL ENDOPEPTIDASE, PROTEASE, CYSTEINE 1; COMPND 6 EC: 3.4.22.34; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CYSTATIN-M; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 29-149; COMPND 13 SYNONYM: CYSTATIN-6, CYSTATIN-E; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGMN, PRSC1; SOURCE 6 EXPRESSION_SYSTEM: LEISHMANIA TARENTOLAE; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 5689; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CST6; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX, CYSTEINE PROTEASE, INHIBITOR, LEGUMAIN, ASPARAGINYL KEYWDS 2 ENDOPEPTIDASE, REACTIVE CENTER LOOP, PAPAIN, CATHEPSIN, CANCER, KEYWDS 3 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.DALL,H.BRANDSTETTER REVDAT 3 29-JUL-20 4N6O 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 11-MAR-15 4N6O 1 JRNL REVDAT 1 11-FEB-15 4N6O 0 JRNL AUTH E.DALL,J.C.FEGG,P.BRIZA,H.BRANDSTETTER JRNL TITL STRUCTURE AND MECHANISM OF AN ASPARTIMIDE-DEPENDENT PEPTIDE JRNL TITL 2 LIGASE IN HUMAN LEGUMAIN. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 54 2917 2015 JRNL REFN ISSN 1433-7851 JRNL PMID 25630877 JRNL DOI 10.1002/ANIE.201409135 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 38725 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2041 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2819 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.28 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE SET COUNT : 153 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3008 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 279 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.24000 REMARK 3 B22 (A**2) : -0.96000 REMARK 3 B33 (A**2) : 1.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.76000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.139 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.125 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.088 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.863 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3154 ; 0.004 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2891 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4286 ; 0.946 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6637 ; 0.672 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 374 ; 5.284 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 151 ;36.573 ;24.636 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 517 ;11.657 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;17.244 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 470 ; 0.054 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3564 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 739 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1505 ; 0.476 ; 2.391 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1504 ; 0.476 ; 2.391 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1876 ; 0.890 ; 3.584 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1877 ; 0.890 ; 3.585 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1649 ; 0.369 ; 2.425 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1650 ; 0.368 ; 2.425 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2402 ; 0.672 ; 3.619 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3767 ; 3.239 ;19.541 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3645 ; 2.866 ;19.076 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4N6O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000082819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9393 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40857 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 48.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4AW9, 4N6L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25 % PEG 4000, 100 MM MES PH 6.5, 200 REMARK 280 MM POTASSIUM IODIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.77500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 289 REMARK 465 ALA A 290 REMARK 465 SER A 291 REMARK 465 SER A 292 REMARK 465 PRO A 293 REMARK 465 VAL A 294 REMARK 465 PRO A 295 REMARK 465 LEU A 296 REMARK 465 PRO A 297 REMARK 465 PRO A 298 REMARK 465 VAL A 299 REMARK 465 THR A 300 REMARK 465 HIS A 301 REMARK 465 LEU A 302 REMARK 465 ASP A 303 REMARK 465 MET B 2 REMARK 465 ASP B 3 REMARK 465 ARG B 4 REMARK 465 PRO B 5 REMARK 465 GLN B 6 REMARK 465 GLU B 7 REMARK 465 ARG B 8 REMARK 465 MET B 9 REMARK 465 VAL B 10 REMARK 465 GLU B 126 REMARK 465 HIS B 127 REMARK 465 HIS B 128 REMARK 465 HIS B 129 REMARK 465 HIS B 130 REMARK 465 HIS B 131 REMARK 465 HIS B 132 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 72 39.60 71.87 REMARK 500 THR A 82 76.41 -118.29 REMARK 500 VAL B 57 -146.88 -135.88 REMARK 500 HIS B 82 38.82 -148.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4N6L RELATED DB: PDB REMARK 900 RELATED ID: 4N6M RELATED DB: PDB REMARK 900 RELATED ID: 4N6N RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 147 AND 148 STARTED OUT AS ASP AND HIS. THE SIDECHAIN OF REMARK 999 ASP ATTACKS THE FOLLOWING AMIDE OF HIS TO FORM A SUCCINIMIDE REMARK 999 RESIDUE SNN. DBREF 4N6O A 26 303 UNP Q99538 LGMN_HUMAN 26 303 DBREF 4N6O B 4 124 UNP Q15828 CYTM_HUMAN 29 149 SEQADV 4N6O GLN A 263 UNP Q99538 ASN 263 ENGINEERED MUTATION SEQADV 4N6O MET B 2 UNP Q15828 EXPRESSION TAG SEQADV 4N6O ASP B 3 UNP Q15828 EXPRESSION TAG SEQADV 4N6O LEU B 125 UNP Q15828 EXPRESSION TAG SEQADV 4N6O GLU B 126 UNP Q15828 EXPRESSION TAG SEQADV 4N6O HIS B 127 UNP Q15828 EXPRESSION TAG SEQADV 4N6O HIS B 128 UNP Q15828 EXPRESSION TAG SEQADV 4N6O HIS B 129 UNP Q15828 EXPRESSION TAG SEQADV 4N6O HIS B 130 UNP Q15828 EXPRESSION TAG SEQADV 4N6O HIS B 131 UNP Q15828 EXPRESSION TAG SEQADV 4N6O HIS B 132 UNP Q15828 EXPRESSION TAG SEQRES 1 A 278 GLY GLY LYS HIS TRP VAL VAL ILE VAL ALA GLY SER ASN SEQRES 2 A 278 GLY TRP TYR ASN TYR ARG HIS GLN ALA ASP ALA CYS HIS SEQRES 3 A 278 ALA TYR GLN ILE ILE HIS ARG ASN GLY ILE PRO ASP GLU SEQRES 4 A 278 GLN ILE VAL VAL MET MET TYR ASP ASP ILE ALA TYR SER SEQRES 5 A 278 GLU ASP ASN PRO THR PRO GLY ILE VAL ILE ASN ARG PRO SEQRES 6 A 278 ASN GLY THR ASP VAL TYR GLN GLY VAL PRO LYS ASP TYR SEQRES 7 A 278 THR GLY GLU ASP VAL THR PRO GLN ASN PHE LEU ALA VAL SEQRES 8 A 278 LEU ARG GLY ASP ALA GLU ALA VAL LYS GLY ILE GLY SER SEQRES 9 A 278 GLY LYS VAL LEU LYS SER GLY PRO GLN ASP HIS VAL PHE SEQRES 10 A 278 ILE TYR PHE THR SNN HIS GLY SER THR GLY ILE LEU VAL SEQRES 11 A 278 PHE PRO ASN GLU ASP LEU HIS VAL LYS ASP LEU ASN GLU SEQRES 12 A 278 THR ILE HIS TYR MET TYR LYS HIS LYS MET TYR ARG LYS SEQRES 13 A 278 MET VAL PHE TYR ILE GLU ALA CYS GLU SER GLY SER MET SEQRES 14 A 278 MET ASN HIS LEU PRO ASP ASN ILE ASN VAL TYR ALA THR SEQRES 15 A 278 THR ALA ALA ASN PRO ARG GLU SER SER TYR ALA CYS TYR SEQRES 16 A 278 TYR ASP GLU LYS ARG SER THR TYR LEU GLY ASP TRP TYR SEQRES 17 A 278 SER VAL ASN TRP MET GLU ASP SER ASP VAL GLU ASP LEU SEQRES 18 A 278 THR LYS GLU THR LEU HIS LYS GLN TYR HIS LEU VAL LYS SEQRES 19 A 278 SER HIS THR GLN THR SER HIS VAL MET GLN TYR GLY ASN SEQRES 20 A 278 LYS THR ILE SER THR MET LYS VAL MET GLN PHE GLN GLY SEQRES 21 A 278 MET LYS ARG LYS ALA SER SER PRO VAL PRO LEU PRO PRO SEQRES 22 A 278 VAL THR HIS LEU ASP SEQRES 1 B 131 MET ASP ARG PRO GLN GLU ARG MET VAL GLY GLU LEU ARG SEQRES 2 B 131 ASP LEU SER PRO ASP ASP PRO GLN VAL GLN LYS ALA ALA SEQRES 3 B 131 GLN ALA ALA VAL ALA SER TYR ASN MET GLY SER ASN SER SEQRES 4 B 131 ILE TYR TYR PHE ARG ASP THR HIS ILE ILE LYS ALA GLN SEQRES 5 B 131 SER GLN LEU VAL ALA GLY ILE LYS TYR PHE LEU THR MET SEQRES 6 B 131 GLU MET GLY SER THR ASP CYS ARG LYS THR ARG VAL THR SEQRES 7 B 131 GLY ASP HIS VAL ASP LEU THR THR CYS PRO LEU ALA ALA SEQRES 8 B 131 GLY ALA GLN GLN GLU LYS LEU ARG CYS ASP PHE GLU VAL SEQRES 9 B 131 LEU VAL VAL PRO TRP GLN ASN SER SER GLN LEU LEU LYS SEQRES 10 B 131 HIS ASN CYS VAL GLN MET LEU GLU HIS HIS HIS HIS HIS SEQRES 11 B 131 HIS MODRES 4N6O ASN A 272 ASN GLYCOSYLATION SITE MODRES 4N6O ASN A 167 ASN GLYCOSYLATION SITE MODRES 4N6O SNN A 147 ASP L-3-AMINOSUCCINIMIDE HET SNN A 147 7 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG D 1 14 HET NAG D 2 14 HET IOD A 404 1 HET IOD A 405 1 HET IOD A 406 1 HET IOD A 407 1 HET IOD A 408 1 HETNAM SNN L-3-AMINOSUCCINIMIDE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM IOD IODIDE ION FORMUL 1 SNN C4 H6 N2 O2 FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 5 IOD 5(I 1-) FORMUL 10 HOH *279(H2 O) HELIX 1 1 GLY A 39 TYR A 41 5 3 HELIX 2 2 ASN A 42 ASN A 59 1 18 HELIX 3 3 PRO A 62 GLU A 64 5 3 HELIX 4 4 THR A 104 VAL A 108 5 5 HELIX 5 5 THR A 109 GLY A 119 1 11 HELIX 6 6 ALA A 121 LYS A 125 5 5 HELIX 7 7 VAL A 163 HIS A 176 1 14 HELIX 8 8 GLU A 190 MET A 195 5 6 HELIX 9 9 TRP A 232 GLU A 244 1 13 HELIX 10 10 THR A 250 THR A 262 1 13 HELIX 11 11 LYS A 273 LYS A 279 5 7 HELIX 12 12 VAL A 280 GLY A 285 1 6 HELIX 13 13 ASP B 20 SER B 38 1 19 HELIX 14 14 ASP B 84 CYS B 88 5 5 HELIX 15 15 PRO B 109 ASN B 112 5 4 SHEET 1 A 6 ILE A 66 MET A 69 0 SHEET 2 A 6 HIS A 29 ALA A 35 1 N ILE A 33 O MET A 69 SHEET 3 A 6 HIS A 140 THR A 146 1 O HIS A 140 N TRP A 30 SHEET 4 A 6 LYS A 181 ILE A 186 1 O VAL A 183 N ILE A 143 SHEET 5 A 6 VAL A 204 THR A 208 1 O TYR A 205 N MET A 182 SHEET 6 A 6 MET A 268 GLY A 271 -1 O TYR A 270 N ALA A 206 SHEET 1 B 3 GLY A 149 SER A 150 0 SHEET 2 B 3 ILE A 153 VAL A 155 -1 O ILE A 153 N SER A 150 SHEET 3 B 3 ASP A 160 HIS A 162 -1 O LEU A 161 N LEU A 154 SHEET 1 C 2 ALA A 218 ASP A 222 0 SHEET 2 C 2 THR A 227 ASP A 231 -1 O GLY A 230 N CYS A 219 SHEET 1 D 5 LEU B 13 LEU B 16 0 SHEET 2 D 5 TYR B 42 LEU B 56 -1 O SER B 54 N ARG B 14 SHEET 3 D 5 ILE B 60 ARG B 74 -1 O PHE B 63 N GLN B 53 SHEET 4 D 5 LYS B 98 VAL B 108 -1 O VAL B 107 N ILE B 60 SHEET 5 D 5 SER B 113 GLN B 123 -1 O GLN B 115 N LEU B 106 SSBOND 1 CYS B 101 CYS B 121 1555 1555 2.03 LINK C THR A 146 N3 SNN A 147 1555 1555 1.35 LINK C2 SNN A 147 N HIS A 148 1555 1555 1.29 LINK C5 SNN A 147 N HIS A 148 1555 1555 1.29 LINK ND2 ASN A 167 C1 NAG D 1 1555 1555 1.45 LINK ND2 ASN A 272 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 CRYST1 44.580 85.550 58.920 90.00 94.61 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022432 0.000000 0.001809 0.00000 SCALE2 0.000000 0.011689 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017027 0.00000